After the complete tumor resection, not all patients with an adrenocortical carcinoma require the previous standard therapy Mitotane. Professors Martin Fassnacht and Massimo Terzolo show this in a clinical trial.
FDA cracks down on off-label drug use messaging – Pharmaceutical Technology
The FDA acknowledged the usefulness of off-label uses for approved drugs for diseases with no approved therapies. Credit: klevo via Shutterstock The US Food and
October 24, 2023